The prevalence of COPD co-morbidities in Serbia: Results of a national survey

npj Primary Care Respiratory Medicine

Volumn 24, Issue , 2014, Pages

  Nagorni Obradovic, Ljudmila M ^a,b   Vukovic, Dejana S ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEMIA; ANTHROPOMETRY; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DYSLIPIDEMIA; FEMALE; FUNCTIONAL DISEASE; HEALTH PRACTITIONER; HEARING IMPAIRMENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREVALENCE; SERBIA; SMOKING; VISUAL IMPAIRMENT; AGED; DAILY LIFE ACTIVITY; DYSLIPIDEMIAS; HEALTH STATUS; HEALTH SURVEY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICAL MODEL;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; COMORBIDITY; DYSLIPIDEMIAS; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SERBIA;

EID: 84904390070     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2014.8     Document Type: Article

References (21)

1. Government of Serbia. Second progress report on the implementation of the poverty reduction strategy in Serbia, 2007 [in Serbian]. http://www.prsp.sr. gov.rs.
2. National WHOHealth accounts. http://www.who.int/nha/country/SCG.pdf.
3. Winkler A. Measuring regional inequality: an index of socio-economic pressure for Serbia. Collection of Papers-Faculty of Geography at University of Belgrade 2012; 60: 81-102.
4. Nielsen R, Johannessen A, Benediktsdottir B, Gislason T, Buist AS, Gulsvik A et al. Present and future costs of COPD in Iceland and Norway: results from BOLD study. Eur Respir J 2009; 34 : 850-857.
5. Aryal S, Diaz-Guzman E, Mannino DM. Prevalence of COPD and comorbidity. In: Rabe KF, Wedzica JA, Wouters EFM (eds). COPD and Comorbidity. European Respiratory Monograph, vol 59. European Respiratory Society: Sheffield, UK, 2013: 1-12.
6. Schnell K, Oweiss C, Lee T, Krishnan JA, Leff B, Wolf JL et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med 2012; 12: 26.
7. Buist AS, McBurnie MA, Vollmer RM, Gillespie S, Burney P, Mannino DM et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750. (Pubitemid 47321907)
8. Hagstad S, Bjerg A, Ekerljung L, Backman H, Lindberg A, Roenmark E et al. Passive smoking exposure is associated with increased risk of COPD in never smokers. Chest 2014; 145: 1298-1304.
9. van Manen JG, Bindels PJ, Dekker EW, Ijzermans CJ, Bottema BJ, van der Zee JS et al. Prevalence of comorbidity in patients with chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001; 54: 287-293. (Pubitemid 32153871)
10. Barr RG, Herbstman J, Speizer FE, Camargo CA. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol 2002; 155: 965-971. (Pubitemid 34517854)
11. Agusti A, Calverley PMA, Celli B, Coxson HO, Edwards LD, Lomas DA et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122.
12. Joo H, Park J, Do Lee S, Oh Y. Comorbidities of chronic obstructive pulmonary disease in Koreans: a population-based study. J Korean Med Sci 2012; 27: 901-906.
13. Maclay JD, NacNee W. Assessment of cardiovascular comorbidity. In: Rabe KF, Wedzica JA, Wouters EFM (eds). COPD and Comorbidity . European Respiratory Monograph, vol 59. European Respiratory Society: Sheffield, UK, 2013: 28-49.
14. Lopez Varela MV, Montes de Oca M, Halbert R, Muino A, Talamo C, Prez-Padilla R et al. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study. Arch Bronconeumol 2013; 49: 468-474.
15. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006; 43: 75-80.
16. Romme EA, Smeenk FW, Wouters EF, Rutten EP. Osteoporosis in COPD. In: Rabe KF, Wedzica JA, Wouters EFM (eds). COPD and Comorbidity . European Respiratory Monograph, vol 59. European Respiratory Society: Sheffield, UK, 2013: 93-104.
17. Cafarella PA, Effing TW, Barton C, Ahmed D, Frith PA. Management of depression and anxiety in COPD. In: Rabe KF, Wedzica JA, Wouters EFM (eds). COPD and Comorbidity . European Respiratory Monograph, vol 59. European Respiratory Society: Sheffield, UK, 2013: 144-163.
18. Hynninen MJ, Breitve MH, Wiborg AB. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res 2005; 59: 429-443. (Pubitemid 41676902)
19. Yohannes AM, Willgoss TG, Baldwin RC. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psych 2010; 25: 1209-1221.
20. Garvey C. Depression in patients with chronic obstructive pulmonary disease. Postgrad Med 2012; 124: 101-109.
21. Gruffydd-Jones K, Marsden HC, Holmes S, Kardos P, Escamilla R, Dal Negro R et al. Utility of COPD Assessment Test (CAT) in primary care consultations: a randomised controlled trial. Prim Care Respir J 2013; 22: 37-43.